ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "B cells"

  • 2018 American Transplant Congress

    Elevated Levels of CD19+ B Cells before or after Rituximab Administration is a Risk Factor for the Early Rejection of a Living Kidney Transplant

    M. Kono,1 H. Shirakawa,2 S. Wakai.1

    1Nephrology, Ohkubo Hospital, Tokyo, Japan; 2Urology, Ohkubo Hospital, Tokyo, Japan.

    [Introduction]Rituximab (RTX) is used for desensitization in highly sensitized patients, such as those undergoing ABO-incompatible (ABOi) kidney transplantation. Although RTX is generally effective, some patients…
  • 2018 American Transplant Congress

    In Vivo Administration of Plerixafor and Bortezomib Results in Bone Marrow Plasma Cell Mobilization and Death While Inducing Biphasic Plasma Cell Apoptosis in Peripheral Blood

    E. Woodle,1 S. Tremblay,1 C. Castro-Rojas,2 S. Knechtle,3 A. Shields,1 R. Alloway,1 H. Singh,2 J. Driscoll,1 D. Hildeman.2

    1U Cincinnati, Cincinnati; 2Cincinnati Children's, Cincinnati; 3Duke, Durham.

    Bone marrow (BM) plasma cells (PC) secreting HLA antibody (Ab) remain a persistent reservoir of donor specific Ab and present a significant hurdle to allograft…
  • 2018 American Transplant Congress

    Genomic Modifications Associated with Epstein Barr Virus+ Post-Transplant Lymphoproliferative Disorder

    M. McPherson,1 Y. Balachandran,1 S. Boyd,2 H. Zimmermann,3 R. Trappe,3 C. Esquivel,1 S. Krams,1 O. Martinez.1

    1Department of Surgery, Stanford University School of Medicine, Stanford, CA; 2Department of Pathology, Stanford University School of Medicine, Stanford, CA; 3Department of Haematology and Oncology, DIAKO Ev. Diakonie-Krankenhaus Bremen, Bremen, Germany.

    Epstein Barr Virus (EBV) is nearly ubiquitous in the human population, yet EBV infection is typically asymptomatic. Nevertheless, immunosuppressed transplant recipients are susceptible to EBV+…
  • 2018 American Transplant Congress

    Pancreas Transplant for Type 2 Diabetes is Associated with Preserved Function, but Impaired Glucose Tolerance: A Comparative Analysis

    S. Doshi, C. Pulitano, D. Al-Adra, A. Norgate, G. Sapisochin, M. Selzner, I. McGilvray, J. Schiff, M. Cattral.

    Multi-Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada.

    Background: The indications and outcomes of pancreas transplantation for type 2 diabetes mellitus (T2DM) remains controversial. The aim of this study was to compare the…
  • 2018 American Transplant Congress

    Analysis of Circulating CD38+/CD138+ Plasma Cells during Development of De Novo Donor Specific Antibody Responses

    N-.N. Chai, G. Wu, I. Kim, S. Jordan, A. Klein.

    CTC/Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

    Purpose: Donor specific antibodies (DSA) that emerge following transplantation are indicative of allogenic sensitization and a predisposing factor for antibody mediated rejection. Though various methods…
  • 2018 American Transplant Congress

    Pilot Study of Plasma Cell Niche-Targeted Therapy for Enhancement of Proteasome Inhibitor Effectiveness

    S. Tremblay,1 C. Castro-Rojas,2 J. Driscoll,1 S. Knechtle,3 A. Shields,1 R. Alloway,1 H. Singh,2 D. Hildeman,2 E. Woodle.1

    1UCincinnati, Cincinnati; 2Cincinnati Children's, Cincinnati; 3Duke, Durham.

    HLA antibody (Ab)-secreting bone marrow (BM) plasma cell (PC) survival depends on niche occupancy via a CXCR4 (PC)-CXCL12 (BM stromal cell) interaction. Plerixafor inhibits CXCR4-CXCL12…
  • 2018 American Transplant Congress

    BETA-2 Score is an Excellent Tool for Monitoring of Islet Allograft Function and Early Detection of Transplant Dysfunction

    P. Bachul,1 J. Gołębiewska,2 L. Basto,1 M. Kijek,1 N. Fillman,1 K. Cieply,1 K. Golab,1 L-.J. Wang,1 M. Tibudan,1 C. Thomas,1 A. Dębska-Ślizień,2 J. Fung,1 P. Witkowski.1

    1Surgery, University of Chicago, Chicago; 2Nephrology, Medical University of Gdańsk, Gdańsk, Poland.

    After validation of BETA-2 scores in our cohort of patients in relation to standard stimulation tests, we decided to assess the practical utility of BETA-2…
  • 2018 American Transplant Congress

    Circulating T Follicular Helper Cells Expand Following Transplantation and Exhibit a CD44hi Phenotype That Correlates with Peak Germinal Center Alloreactivity

    G. La Muraglia II, M. Wagener, M. Ford, R. Badell.

    Emory Transplant Center, Atlanta.

    It is increasingly well-recognized that donor-specific antibodies (DSA) play a significant role in the development of chronic rejection and fibrosis that contribute to late renal…
  • 2018 American Transplant Congress

    Impact of the New KAS on Transplant Rates in Highly-HLA Sensitized (HS) Patients after Desenstization (DES): 3yrs Post Implementation

    A. Vo, E. Huang, N. Ammerman, S. Williamson, C. Myers, A. Peng, R. Najjar, S. Sethi, K. Lim, S. Jordan.

    Kidney Transplant, Cedars-Sinai Medical Center, LA, CA.

    Introduction: The KAS aims to increase equity in organ allocation for broadly sensitized (HS) patients, especially (CPRA 99-100%). Coupling desensitization (DES) + KAS likely will…
  • 2018 American Transplant Congress

    IL-10 Requirement in In Vitro Expanded Breg-Mediated Allograft Tolerance is Tissue Specific

    C. Dai, K. Lee, L. Kojima, K. Deng, S. Kimura, C. Rickert, H. Yeh, J. Markmann.

    Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.

    Introduction:Regulatory B cells (Bregs) have shown several multiple mechanisms of suppression, including Treg induction and IL-10 production. Consistent with work of other groups on Breg…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 35
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences